These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 4448539)

  • 21. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood nephrotic syndrome with minimal histopathologic change: responsiveness to prednisone therapy.
    Harner M
    J Iowa Med Soc; 1972 Nov; 62(11):588-91. PubMed ID: 5086692
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 25. [Incidence in the past decade of nephrotic syndrome in childhood Therapeutic result of the use of 3 corticosteroids].
    Bosco Borghesan A; Cutaja I; Maringhini S
    Minerva Pediatr; 1980 Aug; 32(15):939-42. PubMed ID: 7464745
    [No Abstract]   [Full Text] [Related]  

  • 26. [Childhood nephrotic syndrome with minimun glomerular lesions (clinical development and therapeutic response in 40 cases)].
    Ruilope LM; Casado S; López de Novales E; Barat A; Alvarez J; Hernando L
    Rev Clin Esp; 1973 Nov; 131(4):313-8. PubMed ID: 4772782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Idiopathic nephrotic syndrome in children (author's transl)].
    Cornu G; Gosseye S; Kumps N
    Acta Paediatr Belg; 1973; 27(5):305-28. PubMed ID: 4779692
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treating juvenile nephrotic syndrome with levamisol: regarding a marketing suspension].
    Manrique-Rodríguez S; Martínez-Fernández-Llamazares C; Sanjurjo-Sáez M
    Farm Hosp; 2010; 34(3):148-9. PubMed ID: 20471571
    [No Abstract]   [Full Text] [Related]  

  • 30. [Childhood idiopathic nephrotic syndrome treated with cyclophosphamide].
    Heerlein A; Corsini N; Rodríguez E; Puga F
    Rev Chil Pediatr; 1981; 52(1):32-4. PubMed ID: 7255777
    [No Abstract]   [Full Text] [Related]  

  • 31. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic approach to the nephrotic syndrome in children].
    Barras MH; Guignard JP
    Rev Med Suisse Romande; 1992 Jul; 112(7):645-51. PubMed ID: 1496216
    [No Abstract]   [Full Text] [Related]  

  • 33. [Follow-up in adolescents and adults with corticoid-sensitive nephrotic syndrome beginning in childhood].
    Esquivel N; Grünberg J; Martínez G
    Bol Med Hosp Infant Mex; 1988 May; 45(5):277-83. PubMed ID: 3408554
    [No Abstract]   [Full Text] [Related]  

  • 34. ["Idiopathic" nephrosis in children].
    Bollgren I; Bergstrand A; Laurén T; Samuelsson A; Törnroth T; Wasserman J; Winberg J
    Lakartidningen; 1972 Nov; 69(49):5773-80. PubMed ID: 4568705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Reduction of proteinuria by enalapril, in children with nephrotic syndrome resistant to prednisone].
    Pérez-Cortés G; Santos-Atherton D; López-Montaño E
    Gac Med Mex; 1988; 124(9-10):371-4. PubMed ID: 2854521
    [No Abstract]   [Full Text] [Related]  

  • 36. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P; Bianchetti MG; Imoberdorf G; Lütschg J; Reymond D; Oetliker OH
    Schweiz Med Wochenschr; 1994 May; 124(19):801-5. PubMed ID: 8209202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinico-pathological study on the nephrotic syndrome in Jamaican children.
    Swaby ED; Shah DJ; Williams WW
    West Indian Med J; 1984 Jun; 33(2):97-105. PubMed ID: 6485322
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hazard-adapted therapy of acquired idiopathic nephrotic syndromes in children].
    Olbing H
    Dtsch Med Wochenschr; 1973 May; 98(21):1079-85. PubMed ID: 4196141
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.